New drug to treat wasting syndrome. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


New drug to treat wasting syndrome. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Common Factor. 1995 Apr;(no 10):19. Unique Identifier : AIDSLINE AIDS/95700372

Abstract: The Food and Drug Administration (FDA) has approved Serostim, a human growth hormone, for use in AIDS clinical trials involving AIDS patients with uncontrolled and unintended weight loss. Previous studies have shown weight gains with the use of Serostim. The drug tends to increase lean body mass as opposed to fat, but it has shown no benefit in slowing the disease progression of AIDS. The drug is expensive, costing $12,600 for a single 12 week course of therapy. Serano Laboratories, Serostim's manufacturer, has applied to the FDA for approval. More information can be obtained by calling Serano Laboratories at (800)714-AIDS.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Cachexia/COMPLICATIONS/*DRUG THERAPY Clinical Trials Drug Approval Drug Therapy/ECONOMICS Human Somatotropin/*THERAPEUTIC USE Weight Gain NEWSLETTER ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDcomplicationscachexia/complications/KWDdrugtherapyclinicaltrialsdrugapprovaldrugtherapy/economicshumansomatotropin/KWDtherapeuticuseweightgainnewsletterarticle
951130
M95B0894

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .